Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trialLucia Del Mastro, Paolo Bruzzi, Enrico Campadelli et al.|The Lancet Oncology|2021Cited by 86
Benefit from letrozole as extended adjuvant therapy after sequential endocrine therapy: A randomized, phase III study of Gruppo Italiano Mammella (GIM).Lucia Del Mastro, Francesca Poggio, Mauro Mansutti et al.|Journal of Clinical Oncology|2019Cited by 13
SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 TrialsBenedetta Conte, Lucia Del Mastro, Luca Boni et al.|Clinical Cancer Research|2023Cited by 7